| P50 | author | Christian Wittekind | Q29950649 |
| | Thomas Berg | Q42981905 |
| P2093 | author name string | Alexander Schaudinn | |
| | Harald Busse | |
| | Johannes Wiegand | |
| | Michael Tröltzsch | |
| | Nicolas Linder | |
| | Nikita Garnov | |
| | Thomas Karlas | |
| | Volker Keim | |
| | Thomas Kahn | |
| | Joachim Mössner | |
| | Stephan Böhm | |
| | David Petroff | |
| | Hannelore Tenckhoff | |
| | Manfred Wiese | |
| | Ingolf Schiefke | |
| P2860 | cites work | The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis | Q25257576 |
| | Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity | Q28297290 |
| | Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 |
| | Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults | Q29614911 |
| | Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 |
| | The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association | Q29617157 |
| | Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis | Q29619888 |
| | pROC: an open-source package for R and S+ to analyze and compare ROC curves | Q30050695 |
| | Transient elastography: Kill two birds with one stone? | Q30454363 |
| | The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population | Q33262505 |
| | Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification | Q33474978 |
| | Approximation of total visceral adipose tissue with a single magnetic resonance image | Q33904279 |
| | Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy | Q34021973 |
| | A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitis | Q34140192 |
| | Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B. | Q34222246 |
| | Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study | Q34315657 |
| | Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. | Q34363246 |
| | Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. | Q34544284 |
| | A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis | Q34585893 |
| | Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease | Q35631734 |
| | Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial | Q36105168 |
| | Best single-slice measurement site for estimating visceral adipose tissue volume after weight loss in obese, Japanese men | Q36207203 |
| | Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance | Q37552186 |
| | Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease | Q37596730 |
| | Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? | Q37767964 |
| | The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan | Q37932842 |
| | Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials | Q37978785 |
| | Software for automated MRI-based quantification of abdominal fat and preliminary evaluation in morbidly obese patients | Q38057672 |
| | The predictive value of steatosis in hepatitis C virus infection | Q38085061 |
| | Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae | Q38111533 |
| | Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification | Q38128548 |
| | Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population | Q39693472 |
| | Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus | Q39694021 |
| | Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. | Q42270258 |
| | Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe | Q43489886 |
| | Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? | Q45206614 |
| | Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations | Q46078112 |
| | Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. | Q51488901 |
| | Alcoholic liver disease. | Q51764048 |
| | Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. | Q51823144 |
| | Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease | Q53100804 |
| | MRI as the new reference standard in quantifying liver steatosis: the need for international guidelines. | Q53137698 |
| | Liver biopsy: The best, not the gold standard | Q56833893 |
| | Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography | Q57735439 |
| | Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy | Q60358131 |
| | A position statement on NAFLD/NASH based on the EASL 2009 special conference | Q61338101 |
| | Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C | Q61764154 |
| | The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD | Q61989968 |
| | Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content | Q80272462 |
| | Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopy | Q82601757 |
| | Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease | Q82648058 |
| | Will they fit? Development of a measurement device to assess body habitus compatibility with MRI bore diameter for emergency trauma imaging | Q83133857 |
| | The effects of fatty deposits on the accuracy of the Fibroscan® liver transient elastography ultrasound system | Q84239625 |
| | Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography | Q84308242 |
| | Magnetic resonance imaging and spectroscopy for quantification of hepatic steatosis: urgent need for standardization! | Q84676981 |
| | Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease | Q87406034 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | steatosis | Q1365091 |
| P304 | page(s) | e91987 | |
| P577 | publication date | 2014-03-17 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy | |
| P478 | volume | 9 | |